scorecard

You Searched For "hetero remdesivir" and got 20 results


Sort By:


Business Insider Latest Story Image
3 mins read

These are the companies that are making Remdesivir in India

Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…

Business Insider Latest Story Image
1 min read

Hetero Healthcare Ltd starts supply of generic Remdesivir

Remdesivir is the only drug approved by the United States Food and Drug Administration (USFDA) for …

PTI   


Business Insider Latest Story Image
1 min read

Fabiflu, Covifor, Cipremi and other drugs approved or under trial for COVID-19 patients in India

There is some good news for Indians — medicines showing promising results to treat coronavirus. Ind…

Preeti Soni   


Business Insider Latest Story Image
2 mins read

COVID-19: Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir

This comes a day after the Drug Controller General of India (DCGI), considering the emergency and u…

PTI   


Business Insider Latest Story Image
6 mins read

Inside the treacherous black market for Remdesivir in India— from private hospitals to distributors

The black market for drugs that could treat COVID-19 is surging in India, especially when it comes …

Business Insider Latest Story Image
2 mins read

These are the companies that are making Remdesivir in India

Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…

Business Insider Latest Story Image
1 min read

Generic COVID-19 drug priced at ₹5,400 per vial by Hyderabad-based Hetero

They will be made available in two equal lots of 10,000 each. One lot will be immediately supp…

Business Insider Latest Story Image
5 mins read

Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study

Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…

Business Insider Latest Story Image
1 min read

Hetero gets DCGI nod to launch COVID-19 drug

"Backed by strong backward integration capabilities, we can ensure that the product is immediately…

PTI   


Business Insider Latest Story Image
4 mins read

Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients

The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…

Business Insider Latest Story Image
4 mins read

Favipiravir shortage may get filled up in a couple of weeks provided people don't hoard

Like Sheth, Varun Mimani, the Head of Supply Chain at 1mg said that the severity and natur…

Business Insider Latest Story Image
1 min read

Hetero to supply 60,000 vials of generic Remdesvir from July 13

Remdesivir is the only drug approved by the United States Food and Drug Administration (USFDA) for …

PTI   


Business Insider Latest Story Image
2 mins read

Cipla says COVID-19 drug Remdesivir will hit market this week

As India faces a shortage of Covid-19 drug Remdesivir, the pharmaceutical company Cipla said it wil…

Business Insider Latest Story Image
2 mins read

These are the companies manufacturing COVID-19 drug Remdesivir in India

The agreements allow these companies to manufacture remdesivir for distribution in 127 count…

Business Insider Latest Story Image
2 mins read

Cipla to sell anti-viral drug remdesivir as Cipremi in India

In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…

Business Insider Latest Story Image
2 mins read

US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months

As a result of an agreement with the drug maker announced earlier this week, the US Department …

Business Insider Latest Story Image
2 mins read

FDA warns against co-administration of remdesivir with CQ or HCQ for COVID-19 patients

Following an evaluation of the emergency use authorization criteria and scientific evidence a…

PTI   


Business Insider Latest Story Image
4 mins read

India allows use of Remdesivir — the only widely approved treatment for COVID-19 —for moderate cases

It also okayed off-label application of tocilizumab, a drug that modifies the immune system or i…

PTI   


Business Insider Latest Story Image
2 mins read

Hetero Healthcare set to supply its generic COVID-19 drug at Rs 5,400 per vial across India

"The launch of Covifor in India is a significant milestone for all of us... Through Covifor, we ho…

PTI   


Business Insider Latest Story Image
2 mins read

Remdesivir, tocilizumab being considered for 'restricted use' on severely ill COVID-19 patients

India currently does not manufacture remdesivir. The four companies -- Hetero, Jubilant Life Scienc…

PTI